Atlas FDA

Biocor/Epic Valves

FDA premarket approval P040021/S039 · decided 2019-03-04

Approval details

PMA number
P040021
Supplement
S039
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Biocor/Epic Valves
Generic name
heart-valve, non-allograft tissue
Applicant
ABBOTT MEDICAL
Date received
2019-02-13
Decision date
2019-03-04
Days to decision
19 days
Decision code
OK30
Product code
LWR
Advisory committee
Cardiovascular
Expedited review
No
Location
St. Paul, MN
Statement
Expansion of a controlled access environment room for the manufacture of tissue heart valves and the installation of two new biological safety cabinets at the Abbott Belo Horizonte, Brazil manufacturing site.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18